Concepedia

K. Soma

KS

5

Publications

359

Citations

5

H-Index

1996

Active since

Affiliations

Pfizer (United States)(Current)

Swedish Medical Center

University of Washington

K. Soma is an author at Pfizer (United States) specializing in antimicrobial therapy, anti-infective agents, and antimicrobial stewardship.

Top concepts

Publications per year

1996–2016

5

Publications

5

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

D L Boyle, K. Soma, J Hodge et al. · Annals of the Rheumatic Diseases · 2014 · 287 citations · Full text

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group

Roy Fleischmann, P.J. Mease, Sergio Schwartzman et al. · Clinical Rheumatology · 2016 · 31 citations · Full text

Measurement of Urethral Closure Function in Women With Stress Urinary Incontinence

Niels Klarskov, D. Scholfield, K. Soma et al. · The Journal of Urology · 2009 · 21 citations

THU0136 Cardiovascular safety findings in rheumatoid arthritis patients treated with tofacitinib (CP-690,550), a novel, oral jak inhibitor

Christina Charles‐Schoeman, P Wicker, Udo Sechtem et al. · Annals of the Rheumatic Diseases · 2012 · 10 citations

[Clinical studies on vancomycin in the treatment of MRSA infection].

K Shimizu, Mavis Orizu, Hiroshi Kanno et al. · PubMed · 1996 · 10 citations

, , +12

Rows per page

1–5 of 5